Skip to main content
. 2022 May-Jun;12(3):257–268. doi: 10.22038/AJP.2022.19714

Table 4.

Frequency of adverse events

Treatment group
Saffron (n=34) Placebo (n=34)
Count % Count % p-value
Headache 4 11.8 4 11.8 1.000
Insomnia 2 5.9 2 5.9 1.000
Dry mouth 1 2.9 1 2.9 1.000
Nausea 3 8.8 2 5.9 1.000
Constipation 1 2.9 2 5.9 1.000
Sweating 2 5.9 2 5.9 1.000
Vomiting 1 2.9 1 2.9 1.000